These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 17064755

  • 1. Changes in blood viscosity with the recombinant tissue plasminogen activator alteplase.
    Hitosugi M, Omura K, Yufu T, Kido M, Niwa M, Nagai T, Tokudome S.
    Thromb Res; 2007; 120(3):447-50. PubMed ID: 17064755
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased whole blood viscosity during coronary artery bypass surgery. Studies to evaluate the effects of soluble fibrin and poloxamer 188.
    Hunter RL, Papadea C, Gallagher CJ, Finlayson DC, Check IJ.
    Thromb Haemost; 1990 Feb 19; 63(1):6-12. PubMed ID: 2339361
    [Abstract] [Full Text] [Related]

  • 7. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J, Aleem AM, Selman SH, Skrzypczak-Jankun E, Lysiak-Szydlowska W, Grafos N, Fryer HJ, Greenfield RS.
    Int J Mol Med; 2007 Nov 19; 20(5):683-7. PubMed ID: 17912461
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of fucoidan, heparin and cyanogen bromide-fibrinogen on the activation of human glutamic-plasminogen by tissue plasminogen activator.
    Bell J, Duhon S, Doctor VM.
    Blood Coagul Fibrinolysis; 2003 Apr 19; 14(3):229-34. PubMed ID: 12695744
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stachybotrydial selectively enhances fibrin binding and activation of Glu-plasminogen.
    Sasaoka M, Wada Y, Hasumi K.
    J Antibiot (Tokyo); 2007 Nov 19; 60(11):674-81. PubMed ID: 18057696
    [Abstract] [Full Text] [Related]

  • 15. Blood and plasma viscosity in experimentally induced hyper- and hypo-fibrinogenaemia.
    Pola P, Flore R, Tondi P.
    Int J Tissue React; 1986 Nov 19; 8(4):333-6. PubMed ID: 2943690
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D, Füredi R, Gecse K, Ghosh S, Falusi B, Bogár L, Roth E, Lantos J.
    Blood Coagul Fibrinolysis; 2007 Oct 19; 18(7):661-7. PubMed ID: 17890954
    [Abstract] [Full Text] [Related]

  • 19. Electrochemical processing of fibrinogen modified-graphite surfaces: effect on plasmin generation from adsorbed plasminogen.
    Alfonsi-Hourdin S, Longchamp S, Gallet O, Nigretto JM.
    Biomaterials; 2006 Jan 19; 27(1):52-60. PubMed ID: 16029886
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
    Lobov S, Croucher DR, Saunders DN, Ranson M.
    Thromb Haemost; 2008 Aug 19; 100(2):319-29. PubMed ID: 18690354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.